Premium
Hemophilic pseudotumor: Multicenter experience over 25‐year period
Author(s) -
Magallón M.,
Monteagudo J.,
Altisent C.,
Ibáñez A.,
RodriguezPérez A.,
Riba J.,
Tusell J.,
MartinVillar J.
Publication year - 1994
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830450202
Subject(s) - medicine , diathesis , bleeding diathesis , retrospective cohort study , surgery , conservative management , pediatrics , platelet , immunology
Pseudotumor is an infrequent manifestation of bleeding diathesis seen in hemophiliacs, the management of which is still controversial. To ascertain the effectiveness of the main therapies of choice, we have reviewed 1,831 patients affected by hemophillas A (1,108) and B (172), von Willebrand's disease (329), and other miscellaneous coagulopathles (222) diagnosed between 1965 and 1990 in a multicentric, retrospective study. Pseudotumor was proven in 21 patients. Replacement therapy was given in 15 cases as the first therapeutic approach, with complete success attained in only two, whereas surgery, which was carried out in 14 patients, completely resolved the process in eight ( P = 0.017). Patients over 40 years of age demonstrated worse prognosis than younger patients ( P = 0.02), but no other clinical parameters were shown to have influenced the patients' evolution. Surgical management was the most effective treatment for pseudotumor, although more conservative therapies cannot be overlooked in selected cases. © 1994 Wiley‐Liss, Inc.